Search
for
Sort by
Research 871–900 of 1000+
- The Role of Micronutrients in Alopecia Areata: A Review
- Microneedle-Based Approaches for Skin Disease Treatment
- Hair follicles, their disorders and their opportunities
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis
- Hair loss in children in South-East Nigeria: common and uncommon cases
- Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Arctiin blocks hydrogen peroxide-induced senescence and cell death though microRNA expression changes in human dermal papilla cells
- Insulin resistance is increased in alopecia areata patients
- Alopecia Areata of the Beard: A Review of the Literature
- Obsessive-compulsive disorder in dermatology
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Physiological Doses of Red Light Induce IL‐4 Release in Cocultures between Human Keratinocytes and Immune Cells
- Herbal Treatment for Dermatologic Disorders
- Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia
- Factors Affecting the Psychosocial Distress of Patients with Alopecia Areata: A Nationwide Study in Korea
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Topical tofacitinib in treatment of alopecia areata
- Alopecia in Cronkhite-Canada syndrome
- Current and future pharmacotherapy for alopecia areata
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Quality of Life in Patients with Alopecia Areata presenting to the Department of Dermatology at a Tertiary Care Hospital of Lahore, Pakistan
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- Alopecia Areata
- PROFILE OF SKIN CHANGES AND ITS ASSOCIATION WITH BIOCHEMICAL PARAMETERS IN HAEMODIALYSIS PATIENTS
- Hair Disorders